semaglutide and atrial fibrillation Metabolic remodelling in fibrillation: manifestations, mechanisms clinical implications Glucagon‐like peptide‐1 receptor agonist semaglutide

Market Size & Highlights The GLP-1 analogues market reached US$ 51.6 Bn in 2024

Today, Im joined by registered dietitian Ashley Koff, author of Your Best Shot, for an evidence-informed conversation about GLP-1s in midlife

Semaglutide 2.4 mg: 14.9% at 68 weeks

Highlights GLP-1 receptor agonists (GLP-1RAs) significantly reduced HbA1c, body weight, and body fat percentage after 12 months in real clinical settings

While the study doesnt prove causation, it adds to growing concerns about the potential risks of these drugs

The authors also acknowledge Professor Hon-Tsen Yu, PhD (Department of Life Science, College of Life Science, National Taiwan University, Taipei, Taiwan) for providing kind support and great cooperation